Status:
COMPLETED
Comparative Performance of PureVision, Acuvue Oasys and O2Optix
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Myopia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The objective of this study is to evaluate the performance of the PureVision Contact Lens compared to Acuvue Oasys Contact lens and O2Optix Contact lens when worn on a daily wear basis.
Eligibility Criteria
Inclusion
- Subject is myopic
- VA correctable to 0.3 LogMAR or better (driving vision)
- Clear central cornea
- Subject uses a lens care system on a regular basis
Exclusion
- Systemic disease affecting ocular health
- Using systemic or topical medications
- Wear monovision, multifocal or toric contact lenses
- Any grade 2 or greater slit lamp findings
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
510 Patients enrolled
Trial Details
Trial ID
NCT00640341
Start Date
February 1 2008
End Date
April 1 2008
Last Update
December 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anderson & Associates
Tampa, Florida, United States, 33612